European Research Training to Decipher The Ub Code identification of potential...
European Research Training to Decipher The Ub Code identification of potential biomarkers and drug targets
Essential role of protein modification by members of the Ubiquitin family: Post-translational modifications (PTM) by members of the Ubiquitin (Ub) family represent an efficient way to regulate protein function at several levels: t...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
RTI2018-097624-B-I00
PROTEOFORMAS EN FISIOPATOLOGIA Y ACCION DE FARMACOS: ESTUDIO...
157K€
Cerrado
SAF2017-87358-C2-1-R
LA DESREGULACION DE LA ESTABILIDAD DE LAS PROTEINAS COMO MEC...
121K€
Cerrado
NOVEL TOOLS IN PD
Novel tools for real time monitoring and quantification of p...
1M€
Cerrado
NeuronAgeScreen
A Drug Discovery and Target Identification Screening Platfor...
150K€
Cerrado
BFU2008-01108
MECANISMOS DE ESPECIFICIDAD QUE REGULAN LA MODIFICACION DE P...
121K€
Cerrado
SUGABACT
THE ROLE OF O GlcNAc IN BACTERIAL SIGNAL TRANSDUCTION AND VI...
100K€
Cerrado
Información proyecto UbiCODE
Duración del proyecto: 64 meses
Fecha Inicio: 2017-08-17
Fecha Fin: 2022-12-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Essential role of protein modification by members of the Ubiquitin family: Post-translational modifications (PTM) by members of the Ubiquitin (Ub) family represent an efficient way to regulate protein function at several levels: to change their localisation, activity, their interaction with partner proteins or their stability at the right time and cellular compartment, according to the cell requirements. Defects in this homeostatic equilibrium result in pathologies such as cancer, neurodegeneration, inflammation or multiple infections. For this reason, this research area has become very attractive for fundamental scientists as well as for the pharmaceutical industry aiming to identify potential targets for therapeutic intervention. Ub family members hold a homeostatic equilibrium within the cell and are interconnected in various ways including the regulation of enzymes that control the modified status of target proteins. Interestingly, Ub and Ub-like (UbL) proteins can modify themselves, forming intricate and complex chains. This landscape has recently expanded with the discovery of the formation of heterologous chains among UbL molecules including SUMO or NEDD8 but also other PTMs such as phosphorylation or acetylation. This unsuspected complexity of what is now known as the «Ubiquitin Code», which is an unknown universal language that needs to be deciphered to understand protein homeostasis and its associated pathologies. To decrypt this complex code requires joint collaborative multidisciplinary efforts at all levels, including the use of distinct molecular systems and model organisms and the latest technological developments to explore chemical, biochemical, molecular, pharmacological and clinical aspects of protein modification by members of the Ub family. UbiCODE represents an unprecedented effort to understand this code in an integrated manner.